New Avenues for Phosphodiesterase Inhibitors in Asthma

Maria Gabriella Matera, Josuel Ora, Francesco Cavalli, Paola Rogliani, Mario Cazzola
ISSN / E-ISSN
— / —
DOI
10.2147/jep.s242961 ↗
Volume · Issue · Pages
Volume 13 · — · 291-302
Publisher
Dove Medical Press Ltd.
Article URL
https://doi.org/10.2147/jep.s242961 ↗
Article details
Unverified
Publication date (each date has its type and source)
01 Mar 2021
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date01 Mar 2021 OpenAlex

Keywords (as given): phosphodiesterase inhibitors; asthma; phosphodiesterase 3; phosphodiesterase 4; phosphodiesterase 5; cyclic AMP; cyclic GMP; second messengers; severe asthma; adjunctive therapy; bronchodilation; anti-inflammatory activity; pulmonary drug delivery; drug tolerability

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Journal of Experimental Pharmacology
Publication date used
01 Mar 2021 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.